• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

爱泼斯坦-巴尔病毒核抗原1招募亲环素A以促进病毒DNA基因组的复制。

Epstein-Barr Virus Nuclear Antigen 1 Recruits Cyclophilin A to Facilitate the Replication of Viral DNA Genome.

作者信息

Xin Shuyu, Du Shujuan, Liu Lingzhi, Xie Yan, Zuo Lielian, Yang Jing, Hu Jingjin, Yue Wenxing, Zhang Jing, Cao Pengfei, Zhu Fanxiu, Lu Jianhong

机构信息

NHC Key Laboratory of Carcinogenesis, The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Department of Hematology, Xiangya Hospital, Central South University, Changsha, China.

Department of Medical Microbiology, School of Basic Medical Science, Central South University, Changsha, China.

出版信息

Front Microbiol. 2019 Dec 13;10:2879. doi: 10.3389/fmicb.2019.02879. eCollection 2019.

DOI:10.3389/fmicb.2019.02879
PMID:31921057
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6923202/
Abstract

Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1)-mediated DNA episomal genome replication and persistence are essential for the viral pathogenesis. Cyclophilin A (CYPA) is upregulated in EBV-associated nasopharyngeal carcinoma (NPC) with unknown roles. In the present approach, cytosolic CYPA was found to be bound with EBNA1 into the nucleus. The amino acid 376-459 of the EBNA1 domain was important for the binding. CYPA depletion attenuated and ectopic CYPA expression improved EBNA1 expression in EBV-positive cells. The loss of viral copy number was also accelerated by CYPA consumption in daughter cells during culture passages. Mechanistically, CYPA mediated the connection of EBNA1 with oriP (origin of EBV DNA replication) and subsequent oriP transcription, which is a key step for the initiation of EBV genome replication. Moreover, CYPA overexpression markedly antagonized the connection of EBNA1 to Ubiquitin-specific protease 7 (USP7), which is a strong host barrier with a role of inhibiting EBV genome replication. The PPIase activity of CYPA was required for the promotion of oriP transcription and antagonism with USP7. The results revealed a strategy that EBV recruited a host factor to counteract the host defense, thus facilitating its own latent genome replication. This study provides a new insight into EBV pathogenesis and potential virus-targeted therapeutics in EBV-associated NPC, in which CYPA is upregulated at all stages.

摘要

爱泼斯坦-巴尔病毒(EBV)核抗原1(EBNA1)介导的DNA游离型基因组复制和维持对于病毒发病机制至关重要。亲环素A(CYPA)在EBV相关鼻咽癌(NPC)中上调,但其作用尚不清楚。在本研究中,发现胞质CYPA与EBNA1结合进入细胞核。EBNA1结构域的氨基酸376 - 459对于这种结合很重要。CYPA缺失会减弱EBV阳性细胞中EBNA1的表达,而异位表达CYPA则会增强其表达。在培养传代过程中,CYPA的消耗也加速了子代细胞中病毒拷贝数的丢失。从机制上讲,CYPA介导了EBNA1与oriP(EBV DNA复制起点)的连接以及随后的oriP转录,这是EBV基因组复制起始的关键步骤。此外,CYPA过表达显著拮抗EBNA1与泛素特异性蛋白酶7(USP7)的连接,USP7是一种强大的宿主屏障,具有抑制EBV基因组复制的作用。CYPA的肽脯氨酰顺反异构酶(PPIase)活性对于促进oriP转录和拮抗USP7是必需的。结果揭示了一种策略,即EBV招募一种宿主因子来对抗宿主防御,从而促进其自身潜伏基因组的复制。本研究为EBV发病机制以及EBV相关NPC中潜在的病毒靶向治疗提供了新的见解,其中CYPA在所有阶段均上调。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b6d/6923202/fe02b317bef3/fmicb-10-02879-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b6d/6923202/edfe9a3f9c3d/fmicb-10-02879-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b6d/6923202/1391bec66394/fmicb-10-02879-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b6d/6923202/0173eb571b6c/fmicb-10-02879-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b6d/6923202/ceb5d7a04b4f/fmicb-10-02879-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b6d/6923202/cb196f0a2763/fmicb-10-02879-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b6d/6923202/579e4839e7dd/fmicb-10-02879-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b6d/6923202/fe02b317bef3/fmicb-10-02879-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b6d/6923202/edfe9a3f9c3d/fmicb-10-02879-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b6d/6923202/1391bec66394/fmicb-10-02879-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b6d/6923202/0173eb571b6c/fmicb-10-02879-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b6d/6923202/ceb5d7a04b4f/fmicb-10-02879-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b6d/6923202/cb196f0a2763/fmicb-10-02879-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b6d/6923202/579e4839e7dd/fmicb-10-02879-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b6d/6923202/fe02b317bef3/fmicb-10-02879-g007.jpg

相似文献

1
Epstein-Barr Virus Nuclear Antigen 1 Recruits Cyclophilin A to Facilitate the Replication of Viral DNA Genome.爱泼斯坦-巴尔病毒核抗原1招募亲环素A以促进病毒DNA基因组的复制。
Front Microbiol. 2019 Dec 13;10:2879. doi: 10.3389/fmicb.2019.02879. eCollection 2019.
2
B Cell-Specific Transcription Activator PAX5 Recruits p300 To Support EBNA1-Driven Transcription.B细胞特异性转录激活因子PAX5招募p300以支持EBNA1驱动的转录。
J Virol. 2020 Mar 17;94(7). doi: 10.1128/JVI.02028-19.
3
Replication licensing of the EBV oriP minichromosome.EBV oriP 微型染色体的复制许可
Curr Top Microbiol Immunol. 2001;258:13-33. doi: 10.1007/978-3-642-56515-1_2.
4
EBNA1-mediated recruitment of a histone H2B deubiquitylating complex to the Epstein-Barr virus latent origin of DNA replication.EBNA1介导的组蛋白H2B去泛素化复合物募集至爱泼斯坦-巴尔病毒DNA复制潜伏起始位点
PLoS Pathog. 2009 Oct;5(10):e1000624. doi: 10.1371/journal.ppat.1000624. Epub 2009 Oct 16.
5
Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.EBNA1的癌风险变体可解除爱泼斯坦-巴尔病毒游离体潜伏期的调控。
Oncotarget. 2017 Jan 31;8(5):7248-7264. doi: 10.18632/oncotarget.14540.
6
Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.鉴定MEF2B、EBF1和IL6R为EB病毒(EBV)核抗原1的直接基因靶点,这些靶点对EBV感染的B淋巴细胞存活至关重要。
J Virol. 2015 Oct 14;90(1):345-55. doi: 10.1128/JVI.02318-15. Print 2016 Jan 1.
7
Small molecule inhibition of Epstein-Barr virus nuclear antigen-1 DNA binding activity interferes with replication and persistence of the viral genome.小分子抑制爱泼斯坦-巴尔病毒核抗原-1的DNA结合活性会干扰病毒基因组的复制和持久性。
Antiviral Res. 2014 Apr;104:73-83. doi: 10.1016/j.antiviral.2014.01.018. Epub 2014 Jan 31.
8
Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter.黄芩素通过抑制 EBNA1 Q 启动子活性抑制 Epstein-Barr 病毒阳性鼻咽癌细胞生长。
Biomed Pharmacother. 2018 Jun;102:1003-1014. doi: 10.1016/j.biopha.2018.03.114. Epub 2018 Apr 5.
9
GAP31 from an ancient medicinal plant exhibits anti-viral activity through targeting to Epstein-Barr virus nuclear antigen 1.来自一种古老药用植物的 GAP31 通过靶向 Epstein-Barr 病毒核抗原 1 表现出抗病毒活性。
Antiviral Res. 2019 Apr;164:123-130. doi: 10.1016/j.antiviral.2019.02.015. Epub 2019 Feb 25.
10
Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance.EB病毒游离体维持中EBNA1六聚体环的结构与功能基础
J Virol. 2017 Sep 12;91(19). doi: 10.1128/JVI.01046-17. Print 2017 Oct 1.

引用本文的文献

1
Epstein-Barr virus-infected nasopharyngeal carcinoma therapeutics: oncoprotein targets and clinical implications.爱泼斯坦-巴尔病毒感染的鼻咽癌治疗:癌蛋白靶点及临床意义
Med Oncol. 2025 Jan 31;42(3):59. doi: 10.1007/s12032-025-02610-x.
2
Epstein-Barr Virus Synergizes with BRD7 to Conquer c-Myc-Mediated Viral Latency Maintenance via Chromatin Remodeling.爱泼斯坦-巴尔病毒与BRD7协同作用,通过染色质重塑克服c-Myc介导的病毒潜伏维持。
Microbiol Spectr. 2023 Feb 2;11(2):e0123722. doi: 10.1128/spectrum.01237-22.
3
Cyclophilin A binds to AKT1 and facilitates the tumorigenicity of Epstein-Barr virus by mediating the activation of AKT/mTOR/NF-κB positive feedback loop.

本文引用的文献

1
Exosomal cyclophilin A as a novel noninvasive biomarker for Epstein-Barr virus associated nasopharyngeal carcinoma.外泌体亲环素 A 作为一种新型的非侵入性生物标志物用于 EBV 相关鼻咽癌。
Cancer Med. 2019 Jun;8(6):3142-3151. doi: 10.1002/cam4.2185. Epub 2019 May 7.
2
Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.EB 病毒 microRNA miR-BART5-3p 抑制 p53 表达。
J Virol. 2018 Nov 12;92(23). doi: 10.1128/JVI.01022-18. Print 2018 Dec 1.
3
Evaluation of circulating EBV microRNA BART2-5p in facilitating early detection and screening of nasopharyngeal carcinoma.
亲环素 A 与 AKT1 结合,通过介导 AKT/mTOR/NF-κB 正反馈环的激活,促进 EBV 的致瘤性。
Virol Sin. 2022 Dec;37(6):913-921. doi: 10.1016/j.virs.2022.09.001. Epub 2022 Sep 6.
4
Cellular Deubiquitylating Enzyme: A Regulatory Factor of Antiviral Innate Immunity.细胞去泛素化酶:抗病毒天然免疫的调控因子
Front Microbiol. 2021 Dec 13;12:805223. doi: 10.3389/fmicb.2021.805223. eCollection 2021.
5
Cyclophilin A Inhibits Human Respiratory Syncytial Virus (RSV) Replication by Binding to RSV-N through Its PPIase Activity.亲环素 A 通过其 PPIase 活性与 RSV-N 结合抑制人呼吸道合胞病毒 (RSV) 复制。
J Virol. 2021 Jul 12;95(15):e0056321. doi: 10.1128/JVI.00563-21.
6
Molecular Mechanisms of DUBs Regulation in Signaling and Disease.DUBs 在信号转导和疾病中的调控的分子机制。
Int J Mol Sci. 2021 Jan 20;22(3):986. doi: 10.3390/ijms22030986.
循环EBV微小RNA BART2-5p在促进鼻咽癌早期检测和筛查中的评估
Int J Cancer. 2018 Dec 15;143(12):3209-3217. doi: 10.1002/ijc.31642. Epub 2018 Nov 15.
4
Cadherin 6 is activated by Epstein-Barr virus LMP1 to mediate EMT and metastasis as an interplay node of multiple pathways in nasopharyngeal carcinoma.E-钙黏蛋白6被爱泼斯坦-巴尔病毒LMP1激活,作为鼻咽癌多种信号通路的交汇节点介导上皮-间质转化和转移。
Oncogenesis. 2017 Dec 22;6(12):402. doi: 10.1038/s41389-017-0005-7.
5
Extracellular vesicles: novel vehicles in herpesvirus infection.细胞外囊泡:疱疹病毒感染中的新型载体
Virol Sin. 2017 Oct;32(5):349-356. doi: 10.1007/s12250-017-4073-9. Epub 2017 Oct 30.
6
Epstein-Barr Virus miR-BART6-3p Inhibits the RIG-I Pathway.EB 病毒 miR-BART6-3p 抑制 RIG-I 通路。
J Innate Immun. 2017;9(6):574-586. doi: 10.1159/000479749. Epub 2017 Sep 7.
7
An update: Epstein-Barr virus and immune evasion via microRNA regulation.最新进展:爱泼斯坦-巴尔病毒与通过微小RNA调控实现的免疫逃逸
Virol Sin. 2017 Jun;32(3):175-187. doi: 10.1007/s12250-017-3996-5. Epub 2017 Jun 26.
8
Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.对从原发性鼻咽癌活检标本中分离出的18株爱泼斯坦-巴尔病毒进行全基因组分析。
J Virol. 2017 Aug 10;91(17). doi: 10.1128/JVI.00301-17. Print 2017 Sep 1.
9
Ribosome Protein L4 is essential for Epstein-Barr Virus Nuclear Antigen 1 function.核糖体蛋白L4对爱泼斯坦-巴尔病毒核抗原1的功能至关重要。
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):2229-34. doi: 10.1073/pnas.1525444113. Epub 2016 Feb 8.
10
Global trends in incidence and mortality of nasopharyngeal carcinoma.全球鼻咽癌发病率和死亡率的趋势。
Cancer Lett. 2016 Apr 28;374(1):22-30. doi: 10.1016/j.canlet.2016.01.040. Epub 2016 Jan 29.